<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1822">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05055895</url>
  </required_header>
  <id_info>
    <org_study_id>2020-383</org_study_id>
    <nct_id>NCT05055895</nct_id>
  </id_info>
  <brief_title>Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:</brief_title>
  <official_title>Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia: A Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gulhane Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gulhane Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drugs with anticholinergic properties are commonly prescribed to older persons despite&#xD;
      growing evidence of their significant adverse effects. However, limited data are available&#xD;
      concerning their contribution to time of onset of delirium. This study aimed to determine the&#xD;
      potential association of higher anticholinergic burden to early-onset of delirium&#xD;
      superimposed dementia in the older adult.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2005</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Actual">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time onset of delirium superimposed dementia</measure>
    <time_frame>12 month</time_frame>
    <description>First attack of delirium onset</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Delirium</condition>
  <condition>Anticholinergic Adverse Reaction</condition>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>early onset deliryum on dementia</arm_group_label>
    <description>It was earlier than The median time of onset of delirium superimposed dementia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delirium on dementia (normal)</arm_group_label>
    <description>It was equal or later than The median time of onset of delirium superimposed dementia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anticholinergic burden</intervention_name>
    <description>The anticholinergic burden (ACB) was assessed using the Anticholinergic Burden Scale.&#xD;
Higher ACB was described as equal or higher than 1.</description>
    <arm_group_label>Delirium on dementia (normal)</arm_group_label>
    <arm_group_label>early onset deliryum on dementia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All participiants enrolled from outpaitent clinic and underwent by comprehesive geriatric&#xD;
        asssessment.&#xD;
&#xD;
        Delirium and dementia status was assessed by the criteria of confusion assessment method&#xD;
        (CAM) and DSM-4 or DSM-5 respectively.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  65 years and older and diagnosis or fellow-up of Alzhemier dementia in outpatient&#xD;
             clinic.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patients with a history of other than Alzhemier dementia or neurodegenerative&#xD;
             disease (epilepsy, multiple sclerosis, Parkinson disease, etc.), terminal illness&#xD;
             (malignancy, advanced organ failure) were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gulhane training and research hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06670</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bilal Katipoglu, MD</last_name>
      <phone>+905543330380</phone>
      <email>drbilal07@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mehmet I NaharcÄ±, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gulhane Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Bilal Katipoglu</investigator_full_name>
    <investigator_title>Geriatric</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholinergic Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

